University of California, San Francisco: Cardiovascular Diseases trials

The registry lists 26 Cardiovascular Diseases studies with University of California, San Francisco as lead sponsor. 8 are open to participants now and 5 have results posted.

Phase 3 5Phase 4 2No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Gauging Outcomes of Total Milk Ingestion on Lipid and gControlRecruitingNCT07087184Not applicable
• Health eHeart BioBankEnrolling by invitationNCT06976502
• Supportive Training After Cardiac Rehabilitation Including Virtual EngagementRecruitingNCT06701188Not applicable
• Patient Care Outreach, Navigation, Technology and Support 2.0RecruitingNCT06648278Not applicable
• Achieving Chronic Care equiTy by leVeraging the Telehealth EcosystemRecruitingNCT06598436Not applicable
• Text Education About Cardiovascular Health and HIV (TEACH-HIV)RecruitingNCT05642858Not applicable
• Secondhand Tobacco Smoke and Cardiovascular DiseaseRecruitingNCT04715568Phase 4
• The Longitudinal Evaluation of Ovarian Aging and Cardiovascular RiskEnrolling by invitationNCT03825120
• Technology-Based Intervention to Promote Heart Health After Cardiac Rehab (Mobile4Heart)CompletedNCT03446313Not applicableResults posted
• Bococizumab HIV Evaluation (B-HIVE) StudyTerminatedNCT02524106Phase 3Results posted
• Effect of Maraviroc on Endothelial Function in HIV-Infected PatientsCompletedNCT00844519Phase 3Results posted
• Effect of Raltegravir on Endothelial Function in HIV-Infected PatientsCompletedNCT00843713Phase 4Results posted
• Intensive Glycemic Control and Skeletal Health StudyCompletedNCT00324350Phase 3Results posted
• The SCULPT-Job Cohort StudyCompletedNCT06965075Not applicable
• ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervention --The SCULPT-Job StudyCompletedNCT04709549Not applicable
• Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)CompletedNCT03207945Phase 3
• Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk FactorsTerminatedNCT01474954
• The Role of Inflammation and Aging in HIV-Associated Cardiovascular RiskCompletedNCT01333644
• Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta BlockersWithdrawnNCT01330654Not applicable
• Mediators of Atherosclerosis in South Asians Living in AmericaActive, not recruitingNCT01207167
• Dose-dependent Effects of Second-hand Smoke on Vascular FunctionCompletedNCT01007760Not applicable
• Endothelial Function and Vein Graft RemodelingCompletedNCT00831090
• The Role of Nitric Oxide Synthase in Circulating Progenitor Cell FunctionCompletedNCT00627068
• Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and CancerCompletedNCT00467220Not applicable
• Chinese Community Smoking Cessation ProjectCompletedNCT00139516Not applicable
• Diuretics, Hypertension, and Arrhythmias Clinical TrialCompletedNCT00000525Phase 3